| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5202 | 2013 |
| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1522 | 2010 |
| Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study JG Coghlan, CP Denton, E Grünig, D Bonderman, O Distler, D Khanna, ... Annals of the rheumatic diseases 73 (7), 1340-1349, 2014 | 885 | 2014 |
| Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial JM Van Laar, D Farge, JK Sont, K Naraghi, Z Marjanovic, J Larghero, ... Jama 311 (24), 2490-2498, 2014 | 754 | 2014 |
| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 708 | 2013 |
| Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis L van Bon, AJ Affandi, J Broen, RB Christmann, RJ Marijnissen, L Stawski, ... New England journal of medicine 370 (5), 433-443, 2014 | 460 | 2014 |
| Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus TRDJ Radstake, O Gorlova, B Rueda, JE Martin, BZ Alizadeh, ... Nature genetics 42 (5), 426-429, 2010 | 457 | 2010 |
| Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis Y Allanore, C Meune, MC Vonk, P Airo, E Hachulla, P Caramaschi, ... Annals of the rheumatic diseases 69 (01), 218-221, 2010 | 311 | 2010 |
| Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis V Smith, AL Herrick, F Ingegnoli, N Damjanov, R De Angelis, CP Denton, ... Autoimmunity reviews 19 (3), 102458, 2020 | 298 | 2020 |
| Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy O Gorlova, JE Martin, B Rueda, BPC Koeleman, J Ying, M Teruel, ... PLoS genetics 7 (7), e1002178, 2011 | 262 | 2011 |
| Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis MC Vonk, Z Marjanovic, FHJ van den Hoogen, S Zohar, ... Annals of the rheumatic diseases 67 (1), 98-104, 2008 | 225 | 2008 |
| Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy MJ Overbeek, MC Vonk, A Boonstra, AE Voskuyl, A Vonk-Noordegraaf, ... European Respiratory Journal 34 (2), 371-379, 2009 | 199 | 2009 |
| The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype B Rueda, J Broen, C Simeon, R Hesselstrand, B Diaz, H Suarez, ... Human molecular genetics 18 (11), 2071-2077, 2009 | 195 | 2009 |
| Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative F van den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis and rheumatism 65 (11), 2737, 2013 | 182 | 2013 |
| The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high … Z Brkic, L van Bon, M Cossu, CG van Helden-Meeuwsen, MC Vonk, ... Annals of the rheumatic diseases 75 (8), 1567-1573, 2016 | 172 | 2016 |
| Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases MC Vonk, MH Sander, FHJ Van Den Hoogen, P Van Riel, FWA Verheugt, ... European Journal of Echocardiography 8 (5), 317-321, 2007 | 166 | 2007 |
| Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial KB Highland, O Distler, M Kuwana, Y Allanore, S Assassi, A Azuma, ... The Lancet Respiratory Medicine 9 (1), 96-106, 2021 | 153 | 2021 |
| Unraveling SSc pathophysiology; the myofibroblast A van Caam, M Vonk, F van den Hoogen, P van Lent, P van der Kraan Frontiers in immunology 9, 2452, 2018 | 148 | 2018 |
| Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study MC Vonk, B Broers, YF Heijdra, E Ton, R Snijder, APJ Van Dijk, ... Annals of the rheumatic diseases 68 (6), 961-965, 2009 | 148 | 2009 |
| Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) AL Herrick, X Pan, S Peytrignet, M Lunt, R Hesselstrand, L Mouthon, ... Annals of the rheumatic diseases 76 (7), 1207-1218, 2017 | 147 | 2017 |
